These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 15494682)

  • 1. The WHO classification of the myelodysplastic syndromes.
    Bain B
    Exp Oncol; 2004 Sep; 26(3):166-9. PubMed ID: 15494682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes.
    Bernasconi P; Klersy C; Boni M; Cavigliano PM; Calatroni S; Giardini I; Rocca B; Zappatore R; Caresana M; Dambruoso I; Lazzarino M; Bernasconi C
    Br J Haematol; 2007 May; 137(3):193-205. PubMed ID: 17408458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The myelodysplastic syndromes: classification and prognosis.
    Komrokji R; Bennett JM
    Curr Hematol Rep; 2003 May; 2(3):179-85. PubMed ID: 12901338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical implications of the World Health Organization's classification of myelodysplastic syndromes.
    Komrokji RS; Bennett JM
    Curr Hematol Rep; 2005 May; 4(3):175-81. PubMed ID: 15865868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Myelodysplastic syndromes--from FAB to WHO classification].
    Kotlarek-Haus S; Haus O
    Pol Arch Med Wewn; 2005 Nov; 114(5):1128-37. PubMed ID: 16789514
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical relevance of cytogenetics in myelodysplastic syndromes.
    Bernasconi P; Boni M; Cavigliano PM; Calatroni S; Giardini I; Rocca B; Zappatore R; Dambruoso I; Caresana M
    Ann N Y Acad Sci; 2006 Nov; 1089():395-410. PubMed ID: 17261783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in myelodysplastic and myeloproliferative types of chronic myelomonocytic leukemia: a retrospective analysis of 83 patients from a single institution.
    Breccia M; Latagliata R; Mengarelli A; Biondo F; Mandelli F; Alimena G
    Haematologica; 2004 Jul; 89(7):866-8. PubMed ID: 15257942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic myelomonocytic leukemia: lost in classification?
    Bowen DT
    Hematol Oncol; 2005 Mar; 23(1):26-33. PubMed ID: 16149105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative review of classification systems in myelodysplastic syndromes (MDS).
    Bennett JM
    Semin Oncol; 2005 Aug; 32(4 Suppl 5):S3-10. PubMed ID: 16085011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving classifications of the myelodysplastic syndromes.
    Komrokji RS; Bennett JM
    Curr Opin Hematol; 2007 Mar; 14(2):98-105. PubMed ID: 17255786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis of myeloid hematologic malignancies: contributions of the 2001 World Health Organization (WHO) classification].
    Leymarie V; Galoisy AC; Falkenrodt A; Lessard M
    Ann Biol Clin (Paris); 2004; 62(5):513-20. PubMed ID: 15355801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is chronic myelomonocytic leukemia more akin to myelodysplastic or myeloproliferative neoplasms and does it matter?
    Tefferi A
    Leuk Lymphoma; 2008 Jul; 49(7):1225-7. PubMed ID: 18604709
    [No Abstract]   [Full Text] [Related]  

  • 13. Myelodysplastic and myeloproliferative disorders in children.
    Hasle H
    Curr Opin Pediatr; 2007 Feb; 19(1):1-8. PubMed ID: 17224655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two new classifications for pediatric myelodysplastic and myeloproliferative disorders.
    Occhipinti E; Correa H; Yu L; Craver R
    Pediatr Blood Cancer; 2005 Mar; 44(3):240-4. PubMed ID: 15368549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myelodysplastic syndromes classification and risk stratification.
    Komrokji RS; Zhang L; Bennett JM
    Hematol Oncol Clin North Am; 2010 Apr; 24(2):443-57. PubMed ID: 20359636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts.
    Mufti GJ; Bennett JM; Goasguen J; Bain BJ; Baumann I; Brunning R; Cazzola M; Fenaux P; Germing U; Hellström-Lindberg E; Jinnai I; Manabe A; Matsuda A; Niemeyer CM; Sanz G; Tomonaga M; Vallespi T; Yoshimi A;
    Haematologica; 2008 Nov; 93(11):1712-7. PubMed ID: 18838480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases.
    Hasle H; Niemeyer CM; Chessells JM; Baumann I; Bennett JM; Kerndrup G; Head DR
    Leukemia; 2003 Feb; 17(2):277-82. PubMed ID: 12592323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic myelomonocytic leukaemia (CMML)--a myelodysplastic or myeloproliferative syndrome?
    Michaux JL; Martiat P
    Leuk Lymphoma; 1993 Jan; 9(1-2):35-41. PubMed ID: 8477199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CMML: a biologically distinct myeloproliferative disease.
    Cortes J
    Curr Hematol Rep; 2003 May; 2(3):202-8. PubMed ID: 12901341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two groups of chronic myelomonocytic leukaemia: myelodysplastic and myeloproliferative. Prognostic implications in a series of a single center.
    González-Medina I; Bueno J; Torrequebrada A; López A; Vallespí T; Massagué I
    Leuk Res; 2002 Sep; 26(9):821-4. PubMed ID: 12127557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.